Sanofi — Investor Relations & Filings
Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K | 2025-11-03 | English | |
| 6-K | 2025-10-31 | English | |
| Sanofi : Déclaration des transactions sur actions propres - Revised | 2025-10-31 | English | |
| Sanofi: Disclosure of trading in own shares - Revised | 2025-10-31 | English | |
| 424B5 | 2025-10-29 | English | |
| 6-K | 2025-10-28 | English |
Browse filings by year
23 years- 2026 127 filings
- 2025 367 filings
- 2024 220 filings
- 2023 220 filings
- 2022 253 filings
- 2021 243 filings
- 2020 234 filings
- 2019 261 filings
- 2018 221 filings
- 2017 245 filings
- 2016 270 filings
- 2015 188 filings
- 2014 229 filings
- 2013 229 filings
- 2012 210 filings
- 2011 300 filings
- 2010 256 filings
- 2009 270 filings
- 2008 53 filings
- 2004 6 filings
- 2003 1 filing
- 2002 1 filing
- 2000 1 filing
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 11357167 | 6-K | 2025-11-03 | English | ||
| 11357168 | 6-K | 2025-10-31 | English | ||
| 8064746 | Sanofi : Déclaration des transactions sur actions propres - Revised | 2025-10-31 | English | ||
| 8064745 | Sanofi: Disclosure of trading in own shares - Revised | 2025-10-31 | English | ||
| 11357169 | 424B5 | 2025-10-29 | English | ||
| 11357170 | 6-K | 2025-10-28 | English | ||
| 10581834 | Communiqué de presse : Sanofi place 3 milliards de dollars d’emprunts obligataires | 2025-10-28 | French | ||
| 10581822 | Press release: Sanofi successfully prices USD 3 billion of bond issue | 2025-10-28 | English | ||
| 11357171 | FWP | 2025-10-28 | English | ||
| 11357172 | FWP | 2025-10-28 | English | ||
| 11357173 | FWP | 2025-10-28 | English | ||
| 11357174 | FWP | 2025-10-28 | English | ||
| 11357175 | FWP | 2025-10-28 | English | ||
| 8050506 | Sanofi : Déclaration des transactions sur actions propres | 2025-10-27 | English | ||
| 11357176 | 424B5 | 2025-10-27 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for Sanofi, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Sanofi via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/1643/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=1643 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=1643 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=1643 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 1643}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Sanofi (id: 1643)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.